Atlas Trials

Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema

Clinical trial NCT03629210 · WITHDRAWN

Trial details

NCT number
NCT03629210
Sponsor
Pradeepa Yoganathan
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2019-09-01
Primary completion
2021-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.